ETHICAL CONSIDERATIONS REGARDING GENETIC DISCRIMINATION IN THE CASE OF HUNTINGTON’S DISEASE

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Scientific Journal, ESJ

• Publication date

  2015-10-29

• Fields of study

  Law, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Genetic Information Nondiscrimination Act (GINA): Public Policy and Medical Practice in the Age of Personalized Medicine

  2012cited by this paper
• Selective justice, genetic discrimination, and insurance: should we single out genes in our laws?

  2010cited by this paper
• Perceptions of genetic discrimination among people at risk for Huntington’s disease: a cross sectional survey

  2009cited by this paper
• Investigating genetic discrimination in Australia: a large‐scale survey of clinical genetics clients

  2008cited by this paper
• Fear of health insurance loss among individuals at risk for Huntington disease

  2008influential reference
• Nobel prize in medicine awarded to MRI pioneers

  2003cited by this paper
• A vision for the future of genomics research

  2003cited by this paper
• Predictive, pre‐natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000

  2003cited by this paper
• Genetic Discrimination: Time to Act

  2003cited by this paper
• Australian empirical study into genetic discrimination

  2002cited by this paper
• Ethics Instruction in an Issues-Oriented Course on Public Health Genetics

  2002cited by this paper
• Medical examinations preceding employment and/or private insurance: a proposal for European guidelines.

  2000cited by this paper
• Psychological impact of genetic testing for Huntington's disease: an update of the literature

  2000cited by this paper
• Healthcare Ethics in a Diverse Society

  2000cited by this paper
• Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease.

  1995cited by this paper
• How trinucleotide repeats may function

  1995cited by this paper
• (Pre-)employment Medical Examinations and the Law, with Particular Reference to the European Union

  1994cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Age at onset and life table risks in genetic counselling for Huntington's disease.

  1992cited by this paper
• Huntington disease and the abuse of genetics.

  1992cited by this paper
• Discrimination as a consequence of genetic testing.

  1992cited by this paper
• Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium.

  1992cited by this paper
• World Federation of Neurology: Research Committee. Research Group on Huntington's chorea. Ethical issues policy statement on Huntington's disease molecular genetics predictive test.

  1989cited by this paper
• Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk.

  1986cited by this paper
• Presymptomatic testing for Huntington's disease.

  1985cited by this paper

• A pilot evaluation of an 8-week mindfulness-based stress reduction program for people with pre-symptomatic Huntington’s disease

  2023cites this paper